Your browser doesn't support javascript.
loading
Percutaneous Balloon-Expandable Stent Implantation to Treat Transverse Aortic Arch Obstruction: Medium- to Long-Term Outcomes of a Retrospective Multicenter Study.
Salavitabar, Arash; Eisner, Mariah; Armstrong, Aimee K; Boe, Brian A; Chisolm, Joanne L; Cheatham, John P; Cheatham, Sharon L; Forbes, Thomas; Jones, Thomas K; Krings, Gregor J; Morray, Brian H; Steinberg, Zachary L; Akam-Venkata, Jyothsna; Voskuil, Michiel; Berman, Darren P.
Afiliação
  • Salavitabar A; The Heart Center, Nationwide Children's Hospital, Columbus, OH (A.S., A.K.A., J.L.C., J.P.C., S.L.C.).
  • Eisner M; Biostatistics Resource at Nationwide Children's Hospital, Columbus, OH (M.E.).
  • Armstrong AK; The Heart Center, Nationwide Children's Hospital, Columbus, OH (A.S., A.K.A., J.L.C., J.P.C., S.L.C.).
  • Boe BA; The Heart Institute, Joe DiMaggio Children's Hospital, Hollywood, FL (B.A.B., T.F., J.A.-V.).
  • Chisolm JL; The Heart Center, Nationwide Children's Hospital, Columbus, OH (A.S., A.K.A., J.L.C., J.P.C., S.L.C.).
  • Cheatham JP; The Heart Center, Nationwide Children's Hospital, Columbus, OH (A.S., A.K.A., J.L.C., J.P.C., S.L.C.).
  • Cheatham SL; The Heart Center, Nationwide Children's Hospital, Columbus, OH (A.S., A.K.A., J.L.C., J.P.C., S.L.C.).
  • Forbes T; The Heart Institute, Joe DiMaggio Children's Hospital, Hollywood, FL (B.A.B., T.F., J.A.-V.).
  • Jones TK; Seattle Children's Hospital, WA (T.K.J., B.H.M., Z.L.S.).
  • Krings GJ; Department of Pediatric Cardiology, Wilhelmina Children's Hospital of the University Medical Center Utrecht, the Netherlands (G.J.K.).
  • Morray BH; Seattle Children's Hospital, WA (T.K.J., B.H.M., Z.L.S.).
  • Steinberg ZL; Seattle Children's Hospital, WA (T.K.J., B.H.M., Z.L.S.).
  • Akam-Venkata J; Department of Medicine, Division of Cardiology, University of Washington, Seattle (Z.L.S.).
  • Voskuil M; The Heart Institute, Joe DiMaggio Children's Hospital, Hollywood, FL (B.A.B., T.F., J.A.-V.).
  • Berman DP; Department of Cardiology, University Medical Center Utrecht, the Netherlands (M.V.).
Circ Cardiovasc Interv ; 17(7): e013729, 2024 Jul.
Article em En | MEDLINE | ID: mdl-38666384
ABSTRACT

BACKGROUND:

Transverse aortic arch obstruction is a challenging lesion for which stent implantation provides a potentially important alternate therapy. The objectives were to evaluate the technical, procedural, and medium-to-long-term clinical outcomes of percutaneous stent implantation of transverse aortic arch obstruction.

METHODS:

This is a retrospective, multicenter study of transverse aortic arch stent implantation. Univariable and multivariable analyses were performed.

RESULTS:

Index catheterization included 187 stent implants in 146 patients. The median age is 14.3 years (interquartile range, 9.3-19), weight is 53 kg (30-69), and follow-up is 53 months (12-120). The most common stent design was open cell (n=90, 48%). Stents overlapped 142 arch vessels (37 carotid arteries) in 118 (81%) cases. Technical and procedural success rates were 100% and 88%, respectively. Lower weight (P=0.018), body surface area (P=0.013), and minimum-to-descending aortic diameter ratio (P<0.001) were associated with higher baseline aortic gradient. The residual gradient was inversely associated with implant and final dilation diameters (P<0.001). The combined incidence of aortic injury and stent-related complications was 14%. There were no reports of abnormal brain scans or stroke. Blood pressure cuff gradient, echocardiographic arch velocity, and hypertension rates improved within 1-year follow-up with increased antihypertensive medication use. Reintervention was reported in 60 (41%) patients at a median of 84 (22-148) months to first reintervention. On multivariable logistic regression, residual aortic gradient >10 mm Hg was associated with increased odds of reintervention at all time points when controlling for each final dilation diameter, weight, and minimum-to-descending aortic diameter ratio.

CONCLUSIONS:

Transverse aortic arch stent implantation has high rates of technical, procedural, and medium-to-long-term clinical success. Aortic gradient >10 mm Hg is associated with increased odds of reintervention at 1-year and most recent follow-ups. Open cell stent design was frequently used for its advantages in conformability, perfusion of arch vessels, low fracture rate, and the ability to perform effective angioplasty of side cells.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Aorta Torácica / Desenho de Prótese / Stents / Angioplastia com Balão Limite: Adolescent / Adult / Child / Female / Humans / Male País como assunto: America do norte Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Aorta Torácica / Desenho de Prótese / Stents / Angioplastia com Balão Limite: Adolescent / Adult / Child / Female / Humans / Male País como assunto: America do norte Idioma: En Ano de publicação: 2024 Tipo de documento: Article